Company Overview
About Enterprise Therapeutics
Enterprise Therapeutics is a British biotechnology company founded in 2012 and headquartered in Brighton, United Kingdom, focused on discovering and developing small-molecule drugs that target ion channels and mucus secretion biology in the airways. The company's scientific foundation draws on the biology of chloride and calcium-activated channels — particularly the TMEM16A chloride channel — which regulate mucus production and hydration in the lungs. Dysfunctional mucus clearance is a common pathological feature of cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and non-CF bronchiectasis, conditions that collectively affect tens of millions of patients globally. By modulating these channels with small molecules, Enterprise Therapeutics aims to develop treatments that restore airway surface liquid and improve mucociliary clearance independent of the genetic mutation driving the disease.
Business Model & Competitive Advantage
Enterprise Therapeutics has raised more than £50M from investors led by Syncona, a London-listed life sciences investment company, alongside other specialist healthcare investors. The company's lead program, ETD002, is a TMEM16A potentiator designed to increase chloride secretion and thin mucus in CF patients who do not respond to or are ineligible for CFTR modulators like Vertex's Trikafta. ETD002 has advanced into clinical development, positioning Enterprise Therapeutics as a rare pure-play ion channel company with a clinical-stage respiratory asset. The company's pipeline also includes compounds targeting mucin hypersecretion and inflammation.
Competitive Landscape 2025–2026
Enterprise Therapeutics competes in the respiratory drug discovery space alongside programs from AstraZeneca, Novartis, and academic spinouts from the Wellcome Sanger Institute and University of California San Francisco. Its focus on ion channel biology as a route to mucus normalization — rather than the gene-correction approach of CFTR modulators — gives it scientific and commercial differentiation, particularly for the large population of CF patients with mutations not addressed by existing modulator therapies, as well as the broader COPD and bronchiectasis markets where no disease-modifying therapies currently exist.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Compare Enterprise Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Enterprise Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Enterprise Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Enterprise Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →